Cost accounting del follow-up annuo per il controllo remoto dei defibrillatori impiantabili

Journal title MECOSAN
Author/s Gabriele Palozzi, Antonio Chirico, Leonardo Calò
Publishing Year 2014 Issue 2014/90
Language Italian Pages 28 P. 71-98 File size 477 KB
DOI 10.3280/MESA2014-090005
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

The study aimed at assessing current direct costs of 1-year implantable cardioverter defibrillator (ICD) follow-up based on Remote Monitoring system compared with conventional quarterly in-hospital traditional follow-ups, considering all direct costs burdened on patients and hospital. Patients (N = 233) with indications for ICD were consecutively recruited in two homogeneous population and randomized at implant to be followed-up for 12 ± 3 months. Direct Costs were calculated distinguishing between provider and patient costs, through an ABC estimation made by empirical observation and direct surveys. Moving from the traditional cost accounting rules, it was estimate that direct costs were significantly reduced in the RM group; any patient could save about € 156/year while the hospital could save about € 20 per patient/year.

Keywords: Cost-analysis, telemedicine, remote monitoring (RM), implantable cardioverter defibrillator (ICD), health technology assessment, health care management.

  1. Agliati M. (1990). La misurazione economica nella gestione d’impresa. Milano: Egea.
  2. Al-Khatib S. M., Piccini J.P., Knight D., Stewart M., Clapp-Channing N. and Sanders G.D. (2010). Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogation in Clinic: Result from a randomized pilot clinical trial. Journal of Cardiovascular Electrophysiology, 21: 545-50. DOI: 10.1111/j.1540-8167.2009.01659.x
  3. Amigoni F. (1988). Le misure nel controllo dell’economia delle imprese. In: Amigoni F. (a cura di), Misurazioni d’Azienda, Vol. I. Milano: Giuffrè.
  4. Anthony R.N. (1989). Sistemi di pianificazione e controllo. Milano: Etas Libri. Automobile Club d’Italia (2011). Fringe benefit. Testo disponibile al sito:, consultato in data 27/01/2011.
  5. Bergmo T.S. (2012). Approaches to economic evaluation in telemedicine. Journal of Telemedicine and Telecare,18: 181-4. DOI: 10.118/1478-7547-7-18
  6. Bikou O., Licka M., Kathoefer S., Katus A., Bauer A. (2010). Cost saving and safety of ICD remote control by telephone: a prospective, observational study. Journal of Telemedicine and Telecare, 16: 403-8. DOI: 10.1258/jtt.2010.090810
  7. Brimson J. A. (1992). Contabilita per attivita. Milano: FrancoAngeli.
  8. Brusa L. (1991), Evoluzione della contabilità dei costi. In Brusa L., Zamprogna L. (a cura di), Pianificazione e controllo di gestione. Milano: Etas Libri.
  9. Brusa L. (2000). Sistemi manageriali di programmazione e controllo. Milano: Giuffrè.
  10. Bubbio A. (a cura di) (2003). Balanced Scorecard. Tradurre la strategia in azione. Torino: ISEDI. Burri H., Heidbüchel H., Jung W., Brugada P.
  11. (2011). Remote monitoring: a cost or an investment?. Europeace, 13: 44-8. DOI: 10.1093/europace/eur082
  12. Cinquini L. (2013). Strumenti per l’analisi dei Costi. Volume I. Fondamenti di cost accounting, Quarta edizione. Torino: Giappichelli. Cooper R., Kaplan R.S. (a cura di) (1991). The
  13. Design of Cost Management Systems, Englewood Cliffs: Prentice Hall.
  14. Drummond M., Tarricone R., Torbica A. (2013). Assessing the Added Value of Health Technologies: Reconciling Different Perspectives. Value in Health, 16(s1): S7-S13. DOI: 10.1016/j.jval.2012.10.007
  15. Drummond M., O’Brien B., Stoddart G.L., Torrance G.W. (1987). Methods for the Economic Evaluation in Health Care Programmes. The Journal of Mental Health Policy and Economics, 2 (1): 43. DOI: 10.1017/s026646230000773x
  16. Epstein A.E., Di Marco J.P., Ellenbogen K.A. Estes III M.N.A., Freedman R.A., Gettes L.S., A. Gillinov M., Gregoratos G., Hammill S.C., Hayes D.L., Hlatky M.A., Newby L.K., Page R.L., Schoenfeld M.H., Silka M.J, Warner Stevenson L., Sweeney M.O. (2013). ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 127: e283-352. DOI: 10.1161/cir.0b013e318276ce9b
  17. Fauchier L., Sadoul N., Kouakam C., Briand F., Chauvin M., Babuty D., Clementy J. (2005). Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator. Pacing Clin Electrophysiology, 28 (Suppl 1): S225-9. DOI: 10.1111/j.1540-8159.2005.00071.x
  18. Ghislandi S., Torbica A., Boriani G. (2013). Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data. BMC Health Services Research, 13: 100. DOI: 10.1186/1472-6963-13-100
  19. Health Communication (2010). Rapporto 2010 sulle malattie croniche in Italia, Dicembre. Heidbuchel H., Lionen P., Foulon S., Wim Huybrechts
  20. W., Ector J., Willems R., Ector H. (2008). Potential role of remote monitoring for scheduled and unscheduled evaluation of patients with an implantable defibrillator. Europeace, 10: 351-357. DOI: 10.1093/europace/eun010
  21. Italian National Institute of Statistics (ISTAT) (2008). Previsioni demografiche dal 1.1.2007 al 1.1.2051. Giugno.
  22. Italian National Institute of Statistics (ISTAT) (2010). Annual cash and accrual wages according with to collective labour agreements per employee per agreement – annual data – euros. Testo disponibile al sito:, consultato in data 09/07/2012.
  23. Italian National Istitute of Statistics (ISTAT) (2010). Annual gross, net hours, holiday pay and other hours reduction according to collective labor agreement. Testo disponibile al sito:, consultato in data 09/07/2012.
  24. Jung W., Rilling A., Bikemeyer R., Miljak T., Meyerfeldt U. (2008). Advances in remote monitoring of implantable pacemakers, cardioverter defibrillators and cardiac resynchronization therapy systems. Springer Science. DOI: 10.1007/s10840-008-9311-5
  25. Kaplan R. S., Atkinson A.A. (1989). Advanced Management Accounting. Englewood Cliffs: Prentice Hall.
  26. Lunati M., Santini M., Bongiorni M.G., Boriani G., Cappato R., Corrado D., Curnis A., Di Biase M., Favale S., Padeletti L., Pedretti R., Proclemer A., Ricci R., Spirito P., Vergara G. (2011). Linee guida AIAC all’impianto di pacemaker, dispositivi per la risincronizzazione cardiaca, defibrillatori automatici e loop recorder. GIAC 2011, 14: 1. Testo disponibile al sito:, consultato in data 30/4/2014.
  27. Mistry H. (2012). Systematic review of studies of the cost-effectiveness of telemedicine and telecare. Changes in economic evidence over twenty years. Journal of Telemedicine and Telecare, 18 :1-6. DOI: 10.1258/jtt.2011.110505
  28. National Social Insurance Agency (INPS) (2010), Net wages 2008. Testo disponibile al sito: Testo disponibile al sito:, consultato in data 30/11/2010.
  29. ONU, Department of Economic and Social Affairs (DESA), Division of Social Policy and Development. Sito internet: Testo disponibile al sito:, consultato in data 20/10/2013.
  30. Proclamer A., Santomauro M., Bongiorni M.G. (2010), Bollettino periodico 2009 – Registro Italiano Pacemaker e Defibrillatori. Registro AIAC, GIAC, vol. 13, numero 3 e 4, Settembre-Dicembre.
  31. World Health Organization (WHO) (2003). Gender, Health and Ageing, Novembre.
  32. World Health Organization (WHO) (2011). Noncommunicable diseases country profiles 2011, Ginevra.
  33. Testo disponibile al sito: http://www.giornalediaritmologia. it/allegati/00907_2010_03/fulltext/01.Proclemer%5B163-192%5D.pdf, consultato
  34. in data 30/4/2014.
  35. Proclamer A., Santomauro M., Lunati M., Bongiorni M.G. (2012). Bollettino periodico 2010 – Registro Italiano Pacemaker e Defibrillatori. Registro AIAC, GIAC 2012, 15 (1): 1-28. Testo disponibile al sito:, consultato in data 30/4/2014.
  36. Proclamer A., Zecchin M., Lunati M. Bongiorni M.G., Padeletti L. (2012). Bollettino periodico 2011 – Registro Italiano Pacemaker e Defibrillatori.
  37. Registro AIAC, GIAC 2012, 15 (3) :145-172. Testo disponibile al sito:
  38. 2012.pdf, consultato in data 30/4/2014. Raatikainen M.J.P., Usimaa P., van Ginneken M.M. et al. (2008). Remote Monitoring of implatable cardioverter defibrillator patient: a safe, time-saving, and cost-effective means for follow-up. Europace, 10: 1145-9. DOI: 10.1016/s0145-4145(09)79568-1
  39. Ricci R.P., Calcagnini G., Castro A., Giada F., Igidbashan D., Landolina M., Melissano D., Perego
  40. G.B., Toselli T. (2011). Consensus document on remote monitoring of cardiac implantable electronic devices: technology, indications, organizational models, acceptability, responsibility and economy issues. Giornale Italiano di Cardiologia, 12: 450-467.
  41. Ricci R.P., Morichelli L., Gargaro A., Laudadio M.T., Santini M. (2009). Home monitoring in patients with implantable cariodia devices: is there a potential reduction of stoke risk? Result form a computer model tested through Monte Carlo simulation. Journal of Cardiovascular Electrophysiology, 20(11): 1244-1251. DOI: 10.1111/j.1540-8167.2009.01543.x
  42. Ricci R.P., Morichelli L., Santini M. (2008). Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace, 10: 351-357. DOI: 10.1093/europace/eum289
  43. Sloan F.A. (1996). Valuing Health Care. Journal of Policy Analysis and Management, 15 (3) :492-495.
  44. DOI: 10.1002/pam.4050150323.VanRoijenL.,Essink-BotM.L.,KoopmanschapM.A.,BonselG.,RuttenF.F.H.(1996).Labourandhealthstatusineconomicevaluationofhealthcare:TheHealthandLabourQuestionnaire.InternationalJournalofTechnologyAssessmentinHealthCare,12(3):405-415.DOI:10.1017/s0266462300009764
  45. Vardas P., Boriani G. (2011). Health economics and the European Hear Rhythm Association. Europace, 13 (suppl. 2): 1-2. DOI: 10.1093/europace/eur090
  46. Varma N., Epstein A.E., Irimpen A., Schweikert R., Love C. (2010). Efficacy and safety of automatic remote monitoring for implantable cardioverterdefibrillator follow-up: the Lumos-T Safely Reduces
  47. Routine Office Device Follow-up (TRUST) trial. Circulation, 122: 325-332. DOI: 10.1161/circulationaha.110.937409
  48. Wade V.A., Karnon J., Elshaug A.G., Hiller J.E. (2010). A systematic review of economic analysis of telehealth services using real time video communication. BMC Healt Serv Res, 10: 233. DOI: 10.1186/1472-6963-10-233

  • L'introduzione di un sistema di prezzi di trasferimento. Il caso dell'Azienda Ospedaliero-Universitaria Pisana Luca Del Bene, Antonello De Vito, Carlo Milli, Fabio Guarracino, in MANAGEMENT CONTROL 2/2018 pp.35
    DOI: 10.3280/MACO2018-002003

Gabriele Palozzi, Antonio Chirico, Leonardo Calò, Cost accounting del follow-up annuo per il controllo remoto dei defibrillatori impiantabili in "MECOSAN" 90/2014, pp 71-98, DOI: 10.3280/MESA2014-090005